Home/Pipeline/ABT-301

ABT-301

Advanced colorectal cancer

Phase 1/2Active

Key Facts

Indication

Advanced colorectal cancer

Phase

Phase 1/2

Status

Active

Company

Anbogen Therapeutics

About Anbogen Therapeutics

AI‑powered precision oncology biotech advancing targeted cancer combos.

View full company profile

Therapeutic Areas